期刊
ANALYTICA CHIMICA ACTA
卷 780, 期 -, 页码 1-6出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.aca.2013.04.003
关键词
4-[4-(4-Dimethylaminophenyl)-5-phenyl-1H-imidazol-2-yl]benzoic acid methyl; ester; Human serum albumin; Binding constant; Binding site
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan [22790160]
- Mitsui Sumitomo Insurance Welfare Foundation
- Nagasaki University
- Grants-in-Aid for Scientific Research [22790160, 25870521, 23590044] Funding Source: KAKEN
The binding of a lophine-based fluorescence probe, 4-[4-(4-dimethylaminophenyl)-5-phenyl-1H-imidazol-2-yl]benzoic acid methyl ester (DAPIM) with human serum albumin (HSA) was investigated by fluorescence spectroscopy under physiological conditions. While DAPIM shows extreme low fluorescence in aqueous solution, DAPIM binding with HSA emits strong fluorescence at 510 nm. The binding constant and binding number determined by Scatchard plot was 3.65 x 10(6) M-1 and 1.07, respectively. Competitive binding between DAPIM and other ligands such as warfarin, valproic acid, diazepam and oleic acid, were also studied fluorometrically. The results indicated that the primary binding site of DAPIM to HSA is site II at subdomain IIIA. DAPIM can be a useful fluorescence probe for the characterization of drug-binding sites. In addition to the interaction study, because the fluorescence intensity of DAPIM increased in proportion to HSA concentration, its potential in HSA assay for serum sample was also evaluated. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据